Publication | Closed Access

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

Alzheimer's DiseaseMedicineDementiaVascular DementiaFrontotemporal DementiaNeurologyNeuroscienceNeurodegenerationAging-associated DiseaseMild-to-moderate AlzheimerPharmacology